Jim Simons Zentalis Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 556,944 shares of ZNTL stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

556,944

Previous 661,682 15.83%

Holding current value

$1.7 Million

Previous $2.71 Million 24.5%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$2.9 - $4.57 $303,740 - $478,652	-104,738 Reduced 15.83%	556,944 $2.04 Million
Q2 2024 Aug 09, 2024	BUY	$4.09 - $16.13 $1.63 Million - $6.45 Million	399,745 Added 152.61%	661,682 $2.71 Million
Q1 2024 May 13, 2024	SELL	$10.83 - $16.49 $512,692 - $780,636	-47,340 Reduced 15.31%	261,937 $4.13 Million
Q4 2023 Feb 13, 2024	BUY	$9.84 - $20.13 $234,585 - $479,899	23,840 Added 8.35%	309,277 $4.69 Million
Q3 2023 Nov 14, 2023	BUY	$19.63 - $28.29 $1.47 Million - $2.12 Million	75,000 Added 35.64%	285,437 $5.73 Million
Q2 2023 Aug 11, 2023	BUY	$17.41 - $30.05 $3.09 Million - $5.34 Million	177,700 Added 542.81%	210,437 $5.94 Million
Q1 2023 May 12, 2023	BUY	$16.14 - $24.94 $528,375 - $816,460	32,737 New	32,737 $563,000
Q2 2022 Aug 12, 2022	SELL	$17.91 - $52.25 $1.96 Million - $5.71 Million	-109,337 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$41.58 - $80.89 $4.55 Million - $8.84 Million	109,337 New	109,337 $5.05 Million
Q4 2021 Feb 11, 2022	SELL	$66.92 - $84.79 $2.1 Million - $2.66 Million	-31,337 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$46.83 - $73.5 $1.47 Million - $2.3 Million	31,337 New	31,337 $2.09 Million
Q1 2021 May 13, 2021	SELL	$35.69 - $52.72 $228,308 - $337,249	-6,397 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$31.71 - $57.97 $202,848 - $370,834	6,397 New	6,397 $332,000

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $174M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account